William Grossman - 17 Jan 2024 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Director
Signature
/s/ Charles N. York II, as Attorney-in-Fact
Issuer symbol
DAWN
Transactions as of
17 Jan 2024
Net transactions value
$0
Form type
3
Filing time
19 Jan 2024, 17:09:38 UTC
Previous filing
21 Jun 2021
Next filing
28 May 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.